Product Code: ETC067303 | Publication Date: Jun 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India virtual clinical trials market is projected to reach USD 255 million by 2031, driven by increasing demand for remote monitoring of clinical trial participants and the need to reduce costs associated with traditional on-site visits. Factors such as advancements in cloud computing, mobile health technologies, artificial intelligence (AI), machine learning, and big data analytics are driving the growth of telemedicine and decentralized clinical studies in India. Virtual clinical trials are expected to revolutionize medical research and provide patients with more convenient access to treatments.
Growing prevalence of chronic diseases: The growing prevalence of chronic conditions such as cancer, cardiovascular disease (CVD) & diabetes along with an aging population is driving demand for effective treatment options which will boost the adoption rate of virtual clinical trials in India. This will enable smooth running of drug development processes while reducing cost overruns due to transportation expenses or time constraints caused by travel restrictions imposed during pandemics like COVID-19. Increasing Focus on Patient Centricity: Pharmaceutical companies have started shifting their focus towards patient centricity from product centricity which has led them towards embracing innovative methods like virtualized platforms that allow remote access & engagement between sponsors & investigators while ensuring safety & quality standards remain intact throughout the study lifecycle . A number of initiatives taken up by various organizations create awareness about the importance & benefits offered by VCTs thereby creating a conducive environment for its adoption across healthcare industry especially during times when it becomes difficult for sites/sponsors/investigators to meet physically due to restriction imposed over international boundaries due Covid 19 or other reasons.
Lack Of Standard Guidelines And Regulatory Framework For Virtual Clinical Trials In India : although Indian government released draft guidelines on conduct virtual trials back in 2018 but still there exist no clear set rules regarding use this methodologies therefore many pharma companies refrains from taking part specially considering ever changing regulatory landscape
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Virtual Clinical Trials Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Virtual Clinical Trials Market Revenues & Volume, 2021 & 2031F |
3.3 India Virtual Clinical Trials Market - Industry Life Cycle |
3.4 India Virtual Clinical Trials Market - Porter's Five Forces |
3.5 India Virtual Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F |
3.6 India Virtual Clinical Trials Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Virtual Clinical Trials Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Virtual Clinical Trials Market Trends |
6 India Virtual Clinical Trials Market, By Types |
6.1 India Virtual Clinical Trials Market, By Study Design |
6.1.1 Overview and Analysis |
6.1.2 India Virtual Clinical Trials Market Revenues & Volume, By Study Design, 2018 - 2031F |
6.1.3 India Virtual Clinical Trials Market Revenues & Volume, By Interventional, 2018 - 2031F |
6.1.4 India Virtual Clinical Trials Market Revenues & Volume, By Expanded Access, 2018 - 2031F |
6.1.5 India Virtual Clinical Trials Market Revenues & Volume, By Observational, 2018 - 2031F |
6.2 India Virtual Clinical Trials Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Virtual Clinical Trials Market Revenues & Volume, By Cardiovascular, 2018 - 2031F |
6.2.3 India Virtual Clinical Trials Market Revenues & Volume, By Oncology, 2018 - 2031F |
6.2.4 India Virtual Clinical Trials Market Revenues & Volume, By Others, 2018 - 2031F |
7 India Virtual Clinical Trials Market Import-Export Trade Statistics |
7.1 India Virtual Clinical Trials Market Export to Major Countries |
7.2 India Virtual Clinical Trials Market Imports from Major Countries |
8 India Virtual Clinical Trials Market Key Performance Indicators |
9 India Virtual Clinical Trials Market - Opportunity Assessment |
9.1 India Virtual Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F |
9.2 India Virtual Clinical Trials Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Virtual Clinical Trials Market - Competitive Landscape |
10.1 India Virtual Clinical Trials Market Revenue Share, By Companies, 2024 |
10.2 India Virtual Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |